产品名称
C8 Ceramide (d17:1/8:0), Avanti Research™ - A Croda Brand 860645P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (860645P-10mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 860645P
shipped in
dry ice
storage temp.
−20°C
SMILES string
OC[C@]([H])(NC(CCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCC
InChI
1S/C25H49NO3/c1-3-5-7-9-10-11-12-13-14-15-17-18-20-24(28)23(22-27)26-25(29)21-19-16-8-6-4-2/h18,20,23-24,27-28H,3-17,19,21-22H2,1-2H3,(H,26,29)/b20-18+/t23-,24+/m0/s1
InChI key
YUKGJYMYMCFXEF-VYQUXUJXSA-N
General description
C8-ceramide or N-octanoyl-D-erythro-sphingosine (C17 base) is a synthetic cell-permeable sphingolipid. It is a combination of C17 analog of sphingosine and octanoic acid. Ceramides are the major lipid component in the outermost layer of the skin, the stratum corneum. C8 Ceramide plays a vital role in inducing apoptotic cell death.
Application
C8 Ceramide (d17:1/8:0) has been used to induce myriocin-treated malignant melanoma cells to increase endogenous ceramide levels.
Packaging
5 mL Amber Glass Screw Cap Vial (860645P-10mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable